. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public
Exchange of Thailand The Board of Directors’ Meeting of Ladprao General Hospital Public Company Limited (the “Company”), No.6/2018, held on August 10, 2018, has approved the financial statements of the
/2561 November 12, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q3/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
November 12, 2004 1/3 No: SN. 130/2019 21 November 2019 Subject: Clarification of Operating Results and Financial Position of the year ended September 30, 2019 Attention: President The Stock Exchange
-single digit growth CAPEX (exclude spectrum) Bt27–30bn (depending on Foreign Exchange Rate) Core service revenue to grow cautiously amid risks and uncertainties at 3 – 5% In 2023, the macroeconomic outlook
- Translation - Ref : LPH/SET 2018/006 March 15, 2018 Subject : Clarification on the Operating Results for Year 2017 period ended December 31, 2017 To : President The Stock Exchange of Thailand The
No CS14/2017 November 13, 2017 Attention President The Stock Exchange of Thailand Subject Declaration of Operating Results for the third quarter of year 2017 For the three-month period ended
-market based financing and unlocking investment that boosts long-term economic growth. "Implementing the Principles will help corporations to access capital and unlock corporate investment in Asia. In
potential growth of the Thai capital and supporting sustainable development while taking into account the environment, society and good governance (ESG).About the Securities and Exchange Commission
exchange rate. Quarter Quarter % THB '000 Q118 Q117 Q118‐Q117 Q118‐Q117 PCBA (Lamphun, Thailand) 2,242,565 43% 1,949,694 38% 292,871 15% PCBA (Jiaxing, China) 813,220